What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Cancer
- Surgery
Ganesh Raghu mainly focuses on Idiopathic pulmonary fibrosis, Internal medicine, Surgery, Pulmonary fibrosis and Intensive care medicine.
His biological study spans a wide range of topics, including Physical therapy, Intensive care and FEV1/FVC ratio.
The various areas that Ganesh Raghu examines in his Internal medicine study include Gastroenterology and Placebo.
His Surgery research focuses on Lung and how it relates to Mortality rate, Health statistics, Rheumatoid arthritis and Bronchitis.
Ganesh Raghu has researched Pulmonary fibrosis in several fields, including Respiratory disease, Molecular biology, Telomerase, Telomere and Etiology.
His Intensive care medicine research integrates issues from Guideline and MEDLINE.
His most cited work include:
- An Official ATS/ERS/JRS/ALAT Statement: Idiopathic Pulmonary Fibrosis: Evidence-Based Guidelines for Diagnosis and Management (4402 citations)
- American thoracic society/European respiratory society international multidisciplinary consensus classification of the idiopathic interstitial pneumonias (3012 citations)
- Idiopathic pulmonary fibrosis: Diagnosis and treatment: International Consensus Statement (2037 citations)
What are the main themes of his work throughout his whole career to date?
His main research concerns Idiopathic pulmonary fibrosis, Internal medicine, Interstitial lung disease, Pathology and Gastroenterology.
His Idiopathic pulmonary fibrosis research includes elements of Pulmonary fibrosis, Clinical trial, Vital capacity and Intensive care medicine.
His Intensive care medicine research is multidisciplinary, incorporating elements of Lung transplantation, MEDLINE, Guideline, Disease and Physical therapy.
His Internal medicine research includes themes of Placebo and Surgery.
The study incorporates disciplines such as Subclinical infection, Hypersensitivity pneumonitis and Lung biopsy in addition to Interstitial lung disease.
His work carried out in the field of Pathology brings together such families of science as Bronchoalveolar lavage, Lung injury and Idiopathic interstitial pneumonia.
He most often published in these fields:
- Idiopathic pulmonary fibrosis (50.34%)
- Internal medicine (44.24%)
- Interstitial lung disease (26.19%)
What were the highlights of his more recent work (between 2018-2021)?
- Internal medicine (44.24%)
- Idiopathic pulmonary fibrosis (50.34%)
- Interstitial lung disease (26.19%)
In recent papers he was focusing on the following fields of study:
The scientist’s investigation covers issues in Internal medicine, Idiopathic pulmonary fibrosis, Interstitial lung disease, Nintedanib and In patient.
Ganesh Raghu combines subjects such as Gastroenterology, Placebo and Cardiology with his study of Internal medicine.
His study explores the link between Placebo and topics such as Tolerability that cross with problems in Exacerbation.
Ganesh Raghu interconnects Vital capacity, Clinical trial, Pulmonologists, Intensive care medicine and Diffusing capacity in the investigation of issues within Idiopathic pulmonary fibrosis.
His studies deal with areas such as Guideline and Disease as well as Intensive care medicine.
His Interstitial lung disease research is multidisciplinary, relying on both Subclinical infection, Radiology, Lung biopsy and Hypersensitivity pneumonitis.
Between 2018 and 2021, his most popular works were:
- Diagnostic accuracy of transbronchial lung cryobiopsy for interstitial lung disease diagnosis (COLDICE): a prospective, comparative study. (71 citations)
- Diagnosis of Hypersensitivity Pneumonitis in Adults. An Official ATS/JRS/ALAT Clinical Practice Guideline. (56 citations)
- Pamrevlumab, an anti-connective tissue growth factor therapy, for idiopathic pulmonary fibrosis (PRAISE): a phase 2, randomised, double-blind, placebo-controlled trial. (44 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Cancer
- Disease
His primary scientific interests are in Idiopathic pulmonary fibrosis, Internal medicine, Interstitial lung disease, FEV1/FVC ratio and Lung biopsy.
His research in Idiopathic pulmonary fibrosis intersects with topics in Vital capacity, Gene expression, Clinical trial, Exacerbation and Respiratory system.
His research links Gastroenterology with Internal medicine.
His research on Interstitial lung disease also deals with topics like
- Bronchoalveolar lavage which intersects with area such as Inflammation and Pulmonary fibrosis,
- Pathology which is related to area like High-resolution computed tomography and Classifier.
His FEV1/FVC ratio study combines topics in areas such as Predictive modelling, Placebo and Subclinical infection.
In his research, Predictive value of tests is intimately related to Usual interstitial pneumonia, which falls under the overarching field of Lung biopsy.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
